Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 90 for child

Edit search filters
  1. A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

    Rochester, MN

  2. A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

    Rochester, MN

  3. Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome

    Rochester, MN

  4. A Study to Evaluate N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC)

  5. A Study to Evaluate Patients with Dravet Syndrome Who Previously Participated in Studies of STK-001

    Rochester, MN

  6. Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

    Rochester, MN

  7. A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome

    Rochester, MN

  8. rTMS for Depressed Teens: A Sham-Controlled Trial, Part 2

    Rochester, MN

  9. A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents with Chronic Migraine

    Rochester, MN

  10. A Study to Assess the Long-Term Safety and Tolerability of TAK-935 (OV935) as Adjunctive Therapy in Patients with Rare Epilepsy

    Rochester, MN

.

Mayo Clinic Footer